Ideagen PLC Exercise of Options and Total Voting Rights (3312X)

TIDMIDEA

RNS Number : 3312X

Ideagen PLC

21 February 2017

21 February 2017

Ideagen plc

("Ideagen" or the "Company")

Exercise of Options and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted 25,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the exercise of share options by an employee.

Application has been made to the London Stock Exchange for the 25,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 24 February 2017.

After Admission, the total number of Ordinary Shares in issue will be 182,529,108 and the total number of voting rights will therefore be 182,529,108. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 
 Enquiries: 
 Ideagen plc                        Tel: [phone] 
 David Hornsby, Chief Executive 
 Graeme Spenceley, Finance 
  Director 
 
 finnCap (Nominated Adviser         Tel: [phone] 
  and Broker) 
 Stuart Andrews / Adrian 
  Hargrave / James Thompson 
  (Corporate Finance) 
 Stephen Norcross (Corporate 
  Broking) 
 

About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L). Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOELLFSVFAIIFID

(END) Dow Jones Newswires

February 21, 2017 02:00 ET (07:00 GMT)